These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8116252)

  • 1. Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein.
    Wang SZ; Rushlow KE; Issel CJ; Cook RF; Cook SJ; Raabe ML; Chong YH; Costa L; Montelaro RC
    Virology; 1994 Feb; 199(1):247-51. PubMed ID: 8116252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus.
    Raabe ML; Issel CJ; Montelaro RC
    Virology; 1999 Jul; 259(2):416-27. PubMed ID: 10388665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with a recombinant envelope protein (rgp90) of EIAV produces a spectrum of vaccine efficacy ranging from lack of clinical disease to severe enhancement.
    Raabe ML; Issel CJ; Cook SJ; Cook RF; Woodson B; Montelaro RC
    Virology; 1998 May; 245(1):151-62. PubMed ID: 9614876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus.
    Hammond SA; Raabe ML; Issel CJ; Montelaro RC
    Virology; 1999 Sep; 262(2):416-30. PubMed ID: 10502520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and immunogenicity of equine infectious anemia virus membrane protein GP90].
    Dai CB; Xiao Y; Lu H; Shen RX; Shao YM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):73-6. PubMed ID: 12870025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine.
    Ma J; Jiang C; Lin Y; Wang X; Zhao L; Xiang W; Shao Y; Shen R; Kong X; Zhou J
    Arch Virol; 2009; 154(5):867-73. PubMed ID: 19363668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic immunization with codon-optimized equine infectious anemia virus (EIAV) surface unit (SU) envelope protein gene sequences stimulates immune responses in ponies.
    Cook RF; Cook SJ; Bolin PS; Howe LJ; Zhou W; Montelaro RC; Issel CJ
    Vet Microbiol; 2005 Jun; 108(1-2):23-37. PubMed ID: 15885929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus.
    Issel CJ; Horohov DW; Lea DF; Adams WV; Hagius SD; McManus JM; Allison AC; Montelaro RC
    J Virol; 1992 Jun; 66(6):3398-408. PubMed ID: 1316455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus.
    Hammond SA; Cook SJ; Falo LD; Issel CJ; Montelaro RC
    Virology; 1999 Feb; 254(1):37-49. PubMed ID: 9927572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine specificity of equine infectious anaemia virus gp90-specific antibodies associated with protective and enhancing immune responses in experimentally infected and immunized ponies.
    Grund CH; Lechman ER; Pezzuolo NA; Issel CJ; Montelaro RC
    J Gen Virol; 1996 Mar; 77 ( Pt 3)():435-42. PubMed ID: 8601778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?
    Leroux C; Cadoré JL; Montelaro RC
    Vet Res; 2004; 35(4):485-512. PubMed ID: 15236678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacy.
    Craigo JK; Li F; Steckbeck JD; Durkin S; Howe L; Cook SJ; Issel C; Montelaro RC
    J Virol; 2005 Mar; 79(5):2666-77. PubMed ID: 15708986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination immunization with EIAV Env protein expressed by recombinant baculovirus and recombinant vaccinia virus containing env gene].
    Dai CM; Zhang XY; Zhang RR; Shao YM; Shen RX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jul; 20(4):410-4. PubMed ID: 15207082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopathogenesis of equine infectious anemia lentivirus disease.
    McGuire TC; O'Rourke KI; Perryman LE
    Dev Biol Stand; 1990; 72():31-7. PubMed ID: 2178127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A proviral derivative from a reference attenuated EIAV vaccine strain failed to elicit protective immunity.
    Ma J; Shi N; Jiang CG; Lin YZ; Wang XF; Wang S; Lv XL; Zhao LP; Shao YM; Kong XG; Zhou JH; Shen RX
    Virology; 2011 Feb; 410(1):96-106. PubMed ID: 21094511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-terminal truncation of the transmembrane protein of an attenuated lentiviral vaccine alters its in vitro but not in vivo replication and weakens its potential pathogenicity.
    Jiang CG; Gao X; Ma J; Lin YZ; Wang XF; Zhao LP; Hua YP; Liu D; Zhou JH
    Virus Res; 2011 Jun; 158(1-2):235-45. PubMed ID: 21539871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern.
    Lin YZ; Shen RX; Zhu ZY; Deng XL; Cao XZ; Wang XF; Ma J; Jiang CG; Zhao LP; Lv XL; Shao YM; Zhou JH
    Antiviral Res; 2011 Nov; 92(2):292-304. PubMed ID: 21893100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Envelope determinants of equine lentiviral vaccine protection.
    Craigo JK; Ezzelarab C; Cook SJ; Chong L; Horohov D; Issel CJ; Montelaro RC
    PLoS One; 2013; 8(6):e66093. PubMed ID: 23785473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains.
    Wang X; Wang S; Lin Y; Jiang C; Ma J; Zhao L; Lv X; Wang F; Shen R; Kong X; Zhou J
    Arch Virol; 2011 Feb; 156(2):353-7. PubMed ID: 21136127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of equine infectious anemia virus is not dependent on ADCC mediating antibodies.
    Tschetter JR; Byrne KM; Perryman LE; McGuire TC
    Virology; 1997 Apr; 230(2):275-80. PubMed ID: 9143283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.